Evaluating appropriate use of blood products in mothers and babies

评估母亲和婴儿血液制品的适当使用

• 批准号: nhmrc : 1027262
• 负责人: A/Pr Christine Roberts
• 金额: $ 26.15万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Partnerships
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/evaluating-appropriate-use-mothers-babies/110555
• 关键词: Evaluating; appropriate; use; blood; products

There has been an increase in blood transfusions following childbirth. Blood transfusions are potentially life-saving treatments for mothers and babies facing life-threatening illnesses or complications involving haemorrhage, however there is potential to be over-transfusing mothers and babies who are exposed to unnecessary risk of adverse outcomes such as infection. We aim to evaluate and improve the safety and appropriate use of blood and blood products during pregnancy, childbirth and the newborn period.

分娩后输血的情况有所增加。对于面临危及生命的疾病或出血并发症的母亲和婴儿来说，输血可能是挽救生命的治疗方法，但也有可能过度使用母亲和婴儿，使他们面临不必要的不良后果风险，如感染。我们的目标是评估和改善妊娠、分娩和新生儿期间血液和血液制品的安全性和适当使用。